Torii Pharmaceutical News and Activities

Torii Pharmaceutical is owned by Shionogi.

Shionogi is one of the...

• Forbes Global 2000 (#1478);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Shionogi is a company listed under the stock ticker 4507 (JP).

Shionogi has a direct presence in 5 countries.

Shionogi has 5 subsidiaries including Shionogi Europe, Shionogi France and Shionogi Italy.

Acquisition, funding and merger involving Shionogi.

• Shionogi has announced the acquisition of Apnimed  (posted on March 24 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Torii Pharmaceutical

• Nobumasa Kondo, Chief Executive Officer
• Chie Shindo, Director
• Akira Okamoto, Director

Popular executive movements at Shionogi

• Takayuki Yamaguchi will join the company as Senior Vice President, Business Development Division on Dec. 1, 2025  (posted on November 3 2025).
• Makoto Kakutani will join the company as Senior Vice President, Central Pharmaceutical Research Institute on Dec. 1, 2025  (posted on November 3 2025).

Create your alert
to follow the executive moves at Torii Pharmaceutical.

Shionogi has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Torii Pharmaceutical

Social media about Torii Pharmaceutical

• Torii Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Torii Pharmaceutical on LinkedIn, X (Twitter) & YouTube